Home > Qtrly Results > NATCO PHARMA

NATCO PHARMA
Quarterly Results Analysis [Mar2026]

NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Revenues ₹739 Cr ₹647 Cr ₹1,363 Cr ₹1,329 Cr ₹1,221 Cr ₹475 Cr ₹1,371 Cr ₹1,363 Cr
Expenses ₹612 Cr ₹489 Cr ₹784 Cr ₹758 Cr ₹673 Cr ₹436 Cr ₹567 Cr ₹558 Cr
Operating Income ₹128 Cr ₹159 Cr ₹579 Cr ₹571 Cr ₹548 Cr ₹39 Cr ₹804 Cr ₹805 Cr
Other Income ₹78 Cr ₹58 Cr ₹100 Cr ₹62 Cr ₹66 Cr ₹176 Cr ₹64 Cr ₹48 Cr
Interest ₹11 Cr ₹10 Cr ₹13 Cr ₹3 Cr ₹10 Cr ₹4 Cr ₹4 Cr ₹5 Cr
Depreciation ₹50 Cr ₹46 Cr ₹52 Cr ₹58 Cr ₹98 Cr ₹47 Cr ₹46 Cr ₹44 Cr
Profit Before Tax ₹144 Cr ₹161 Cr ₹614 Cr ₹572 Cr ₹506 Cr ₹164 Cr ₹818 Cr ₹804 Cr
Profit After Tax ₹233 Cr ₹140 Cr ₹518 Cr ₹480 Cr ₹406 Cr ₹132 Cr ₹677 Cr ₹669 Cr
EPS ₹14.97 ₹8.46 ₹28.96 ₹26.85 ₹22.72 ₹7.43 ₹37.84 ₹37.35
Industry Peers & Returns1W1M1Y
NATCO PHARMA 3.9% -24.6% -1.6%
SUN PHARMACEUTICAL INDUSTRIES 3.5% -1.5% 9%
DIVIS LABORATORIES 1.1% -1.1% 0.8%
TORRENT PHARMACEUTICALS -0.2% -0.3% 35%
CIPLA 3.1% 1% -11.3%
DR REDDYS LABORATORIES 1.1% -2.1% -5.6%
MANKIND PHARMA 7.7% 0.9% 2.1%
LUPIN 2.7% 2.4% 17%
ZYDUS LIFESCIENCES 0.6% 4.7% 10%

NATCO PHARMA Quarterly Revenues

Revenues
Q-o-Q

14.18 %

Y-o-Y

-39.47 %

Quarters Revenues % Change
Mar2026 ₹739 Cr
14.18
Dec2025 ₹647 Cr
-52.51
Sep2025 ₹1,363 Cr
2.57
Jun2025 ₹1,329 Cr
8.84
Mar2025 ₹1,221 Cr
157.16
Dec2024 ₹475 Cr
-65.37
Sep2024 ₹1,371 Cr
0.62
Jun2024 ₹1,363 Cr -

NATCO PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-19.60 %

Y-o-Y

-76.72 %

Quarters Operating Profit % Change
Mar2026 ₹128 Cr
-19.60
Dec2025 ₹159 Cr
-72.60
Sep2025 ₹579 Cr
1.44
Jun2025 ₹571 Cr
4.18
Mar2025 ₹548 Cr
1,312.63
Dec2024 ₹39 Cr
-95.18
Sep2024 ₹804 Cr
-0.06
Jun2024 ₹805 Cr -
Operating Margins
Q-o-Q

-29.61 %

Y-o-Y

-61.55 %

Quarters Operating Margin% % Change
Mar2026 17.26%
-29.61
Dec2025 24.52%
-42.29
Sep2025 42.49%
-1.12
Jun2025 42.97%
-4.28
Mar2025 44.89%
449.45
Dec2024 8.17%
-86.07
Sep2024 58.66%
-0.68
Jun2024 59.06% -

NATCO PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

66.17 %

Y-o-Y

-42.54 %

Quarters Profit After Tax % Change
Mar2026 ₹233 Cr
66.17
Dec2025 ₹140 Cr
-72.89
Sep2025 ₹518 Cr
7.83
Jun2025 ₹480 Cr
18.30
Mar2025 ₹406 Cr
206.65
Dec2024 ₹132 Cr
-80.43
Sep2024 ₹677 Cr
1.20
Jun2024 ₹669 Cr -
PAT Margins
Q-o-Q

45.55 %

Y-o-Y

-5.05 %

Quarters PAT Margin(%) % Change
Mar2026 31.57 %
45.55
Dec2025 21.69 %
-42.92
Sep2025 38 %
5.15
Jun2025 36.14 %
8.69
Mar2025 33.25 %
19.22
Dec2024 27.89 %
-43.47
Sep2024 49.34 %
0.57
Jun2024 49.06 % -

NATCO PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

76.95 %

Y-o-Y

-34.11 %

Quarters EPS % Change
Mar2026 ₹14.97
76.95
Dec2025 ₹8.46
-70.79
Sep2025 ₹28.96
7.86
Jun2025 ₹26.85
18.18
Mar2025 ₹22.72
205.79
Dec2024 ₹7.43
-80.36
Sep2024 ₹37.84
1.31
Jun2024 ₹37.35 -

You may also like the below Video Courses